VEGFA and colorectal carcinoma: Notably, we found that while exosomes released by metastatic CRC cells led to an up-regulation of markers specific to activated stromal fibroblasts and enhanced expression of CAF-derived cytokines and VEGF, the administration of MK-2206 (1 μM) impeded these effects to some extent (Figure 3 G-I(Fig. 3)).